Your browser doesn't support javascript.
loading
Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study.
Verbeek, Martijn W C; Rodríguez, Beatriz Soriano; Sedek, Lukasz; Laqua, Anna; Buracchi, Chiara; Buysse, Malicorne; Reiterová, Michaela; Oliveira, Elen; Morf, Daniela; Oude Alink, Sjoerd R; Barrena, Susana; Kohlscheen, Saskia; Nierkens, Stefan; Hofmans, Mattias; Fernandez, Paula; de Costa, Elaine Sobral; Mejstrikova, Ester; Szczepanski, Tomasz; Slota, Lukasz; Brüggemann, Monika; Gaipa, Giuseppe; Grigore, Georgiana; van Dongen, Jacques J M; Orfao, Alberto; van der Velden, Vincent H J.
Afiliação
  • Verbeek MWC; Laboratory for Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Rodríguez BS; Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.
  • Sedek L; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.
  • Laqua A; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Buracchi C; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
  • Buysse M; Department of Microbiology and Immunology, Medical University of Silesia in Katowice, Zabrze, Poland.
  • Reiterová M; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia in Katowice, Katowice, Poland.
  • Oliveira E; Department of Hematology, University of Schleswig-Holstein, Kiel, Germany.
  • Morf D; Centro Tettamanti, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
  • Oude Alink SR; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.
  • Barrena S; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.
  • Kohlscheen S; CLIP-Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
  • Nierkens S; Pediatrics Institute IPPMG, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Hofmans M; Institute for Laboratory Medicine, Aarau, Switzerland.
  • Fernandez P; Laboratory for Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • de Costa ES; Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.
  • Mejstrikova E; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.
  • Szczepanski T; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Slota L; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
  • Brüggemann M; Department of Hematology, University of Schleswig-Holstein, Kiel, Germany.
  • Gaipa G; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Grigore G; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.
  • van Dongen JJM; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.
  • Orfao A; Institute for Laboratory Medicine, Aarau, Switzerland.
  • van der Velden VHJ; Pediatrics Institute IPPMG, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Article em En | MEDLINE | ID: mdl-37740440

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Idioma: En Revista: Cytometry B Clin Cytom Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Idioma: En Revista: Cytometry B Clin Cytom Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda